Why the study?
Do HRV entropy measures using recently published parameter sets predict mortality in hemodialysis patients?
Do HRV entropy measures using recently published parameter sets predict mortality in hemodialysis patients?
HRV entropy measures using non-optimized, recently published parameter sets can significantly predict mortality in end-stage renal disease patients, offering a non-invasive tool for cardiovascular risk stratification.
Entropy measures with optimized thresholds may aid mortality prediction in hemodialysis; hypothesis-generating and requires prospective validation before clinical use.
Heart rate variability (HRV) analysis is a non-invasive tool for assessing cardiac health. Entropy measures quantify the chaotic properties of HRV, but they are sensitive to the choice of their required parameters. Previous studies therefore have performed parameter optimization, targeting solely their particular patient cohort. In contrast, this work aimed to challenge entropy measures with recently published parameter sets, without time-consuming optimization, for risk prediction in end-stage renal disease patients. Approximate entropy, sample entropy, fuzzy entropy, fuzzy measure entropy, and corrected approximate entropy were examined. In total, 265 hemodialysis patients from the ISAR (rISk strAtification in end-stage Renal disease) study were analyzed. Throughout a median follow-up time of 43 months, 70 patients died. Fuzzy entropy and corrected approximate entropy (CApEn) provided significant hazard ratios, which remained significant after adjustment for clinical risk factors from literature if an entropy maximizing threshold parameter was chosen. Revealing results were seen in the subgroup of patients with heart disease (HD) when setting the radius to a multiple of the data’s standard deviation ( r = 0.2 · σ ); all entropies, except CApEn, predicted mortality significantly and remained significant after adjustment. Therefore, these two parameter settings seem to reflect different cardiac properties. This work shows the potential of entropy measures for cardiovascular risk stratification in cohorts the parameters were not optimized for, and it provides additional insights into the parameter choice.
No takes yet. Share an insight, caveat, or question.
Hagmair et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: